WallachBeth Capital Announces Pricing of 60 Degrees Pharmaceuticals $2.4 Million Public Offering
JERSEY CITY, N.J., Jan. 30, 2024 /PRNewswire/ — WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that 60 Degrees Pharmaceuticals, Inc. (“60P”), (NASDAQ: SXTP; SXTPW) specialists in developing and marketing medicines for infectious diseases, announced today the pricing of its public offering of 5,260,901 units (the “Units”) at a price to the public of $0.385 per Unit and 999,076 pre‑funded units (the “Pre‑Funded Units”) at a price to the public of $0.375 per Pre‑Funded Unit. The closing of the offering is expected to occur on or about January 31, 2024, subject to the satisfaction of customary closing conditions.
Related news for (SXTP)
- 60 Degrees Pharmaceuticals Announces Pricing of Up to $10 Million Public Offering
- 24/7 Market News Snapshot 15 July, 2025 – 60 Degrees Pharmaceuticals, Inc. Common Stock (NASDAQ:SXTP)
- 60 Degrees Pharmaceuticals Targets Human and Canine Babesiosis Markets With Tafenoquine
- Today’s Top Performers: MoBot’s Market Review 07/15/25 07:00 AM
- 60 Degrees Pharmaceuticals Defines Potential Human Babesiosis Market Size for ARAKODA® (tafenoquine): Annual Max TAM, Sales of $245 Million; Cumulative through Patent Expiration, $1.1 Billion